Mechanism of Ret dysfunction by Hirschsprung mutations affecting its extracellular domain

Human Molecular Genetics

Volumn 5, Issue 10, 1996, Pages 1577-1580

  Iwashita, Toshihide ^a   Murakarni, Hideki ^a   Asai, Naoya ^a   Takahashi, Masahide ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; EXTRACELLULAR MATRIX; FAMILIAL DISEASE; FRAMESHIFT MUTATION; GENE MUTATION; HIRSCHSPRUNG DISEASE; HUMAN; MISSENSE MUTATION; MOUSE; MULTIPLE ENDOCRINE NEOPLASIA; NERVE CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTO ONCOGENE;

EID: 0029798406     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/5.10.1577     Document Type: Article

References (36)

1. Lyonnet, S., Bolino, A., Pelet, A., Abel, L., Nihoul-Fekete, C., Briard, M.L., Mok-Siu, V., Kaariainen, H., Martucciello, G., Lerone, M., Puliti, A., Luo, Y., Weissenbach, J., Devoto, M., Munnich, A. and Romeo, G. (1993) A gene for Hirschsprung disease maps to the proximal long arm of chromosome 10. Nature Genet., 4, 346-350.
2. Angrist, M., Kauffman, E., Slaugenhaupt, S.A., Matise, T.C., Puffenberger, E.G., Washington, S.S., Lipson, A., Cass, D.T., Reyna, T., Weeks, D.E., Sieber, W. and Chakravarti, A. (1993) A gene for Hirschsprung disease (megacolon) in the pericentromeric region of human chromosome 10. Nature Genet., 4, 351-356.
3. Puffenberger, E.G., Kauffman, E.R., Bolk, S., Matise, T.C., Washington, S.S., Angrist, M., Weissenbach, J., Garver, K.L., Mascari, M., Ladda, R., Slaugenhaupt, S.A. and Chakravarti, A. (1994) Identity-by-descent and association mapping of a recessive gene for Hirschsprung disease on chromosome 13q22. Hum. Mol. Genet., 3, 1217-1225.
4. Romeo, G., Ronchetto, P., Luo, Y., Barone, V., Seri, M., Ceccherini, I., Pasini, B., Bocciardi, R., Lerone, M., Kaariainen, H. and Martucciello, G. (1994) Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature, 367, 377-378.
5. Edery, P., Lyonnet, S., Mulligan, L.M., Pelet, A., Dow, E., Abel, L., Holder, S., Nihoul-Fekete, C., Ponder, B.A.J. and Munnich, A. (1994) Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature, 367, 378-380.
6. Yin, L., Barone, V., Seri, M., Bolino, A., Bocciardi, R., Ceccherini, I., Pasini, B., Tocco, T., Lerone, M., Cywes, S., Moore, S., Vanderwinden, J.M., Abramowicz, M.J., Kristoffersson, U., Larsson, L.T., Hamel, B.C.J., Silengo, M., Martucciello, G. and Romeo, G. (1994) Heterogeneity and low detection rate of RET mutations in Hirschsprung disease. Eur. J. Hum. Genet., 2, 272-280.
7. Angrist, M., Bolk, S., Thiel, B., Puffenberger, E.G., Hofstra, R.M., Buys, C.H.C.M., Cass, D.T. and Chakravarti, A. (1995) Mutation analysis of the RET receptor tyrosine kinase in Hirschsprung disease. Hum. Mol. Genet., 4, 821-830.
8. Attie, T., Pelet, A., Edery, P., Eng, C., Mulligan, L.M., Amiel, J., Boutrand, L., Beldjord, C., Nihoul-Fekete, C., Munnich, A., Ponder, B.A.J. and Lyonnet, S. (1995) Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease. Hum. Mol. Genet., 4, 1381-1386.
9. Mulligan, L.M., Eng, C., Attie, T., Lyonnet, S., Marsh, D.J., Hyland, V.J., Robinson, B.G., Frilling, A., Verellen-Dumoulin, C., Safar, A., Venter, D.J., Munnich, A. and Ponder, B.A.J. (1994) Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene. Hum. Mol. Genet., 3, 2163-2167.
10. Puffenberger, E.G., Hosoda, K., Washington, S.S., Nakao, K., de Wit, D., Yanagisawa, M. and Chakravarti, A. (1994) A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell, 79, 1257-1266.
11. Chakravarti, A. (1996) Endothelin receptor-mediated signaling in Hirschsprung disease. Hum. Mol. Genet., 5, 303-307.
12. Kusafuka, T., Wang, Y. and Puri, P. (1996) Novel mutations of the endothelin-B receptor gene in isolated patients with Hirschsprung's disease. Hum. Mol. Genet., 5, 347-349.
13. Auricchio, A., Casari, G., Staiano, A. and Ballabio, A. (1996) Endothelin-B receptor mutations in patients with isolated Hirschsprung disease from a non-inbred population. Hum. Mol. Genet., 5, 351-354.
14. Amiel, J., Attie, T., Jan, D., Pelet, A., Edery, P., Bidaud, C., Lacombe, D., Tam, P., Simeoni, J., Flori, E., Nihoul-Fekete, C., Munnich, A. and Lyonnet, S. (1996) Heterozygous endothelin receptor B (EDNRB) mutations in isolated Hirschsprung disease. Hum. Mol. Genet., 5, 355-357.
15. Schuchardt, A., D'Agati, V., Larsson-Blomberg, L., Costantini, F. and Pachnis, V. (1994) Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature, 367, 380-383.
16. Baynash, A.G., Hosoda, K., Giaid, A., Richardson, J., Emoto, N., Hammer, R. and Yanagisawa, M. (1994) Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell, 79, 1277-1285.
17. Hosoda, K., Hammer, R., Richardson, J., Baynash, A., Cheung, J., Giaid, A. and Yanagisawa, M. (1994) Targeted and natural (Piebald-Lethal) mutations of endothelin-B receptor gene produces megacolon associated with spotted coat color in mice. Cell, 79, 1267-1276.
18. Pasini, B., Borrello, M.G., Greco, A., Bongarzone, I., Luo, Y., Mondellini, P., Alberti, L., Miranda, C., Arighi, E., Bocciardi, R., Seri, M., Barone, V., Radice, M.T., Romeo, G. and Pierotti, M.A. (1995) Loss of function effect of RET mutations causing Hirschsprung disease. Nature Genet., 10, 35-40.
19. Takahashi, M., Buma, Y., Iwamoto, T., Inaguma, Y., Ikeda, H. and Hiai, H. (1988) Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains. Oncogene, 3, 571-578.
20. Takahashi, M., Buma, Y. and Hiai, H. (1989) Isolation of ret proto-oncogene cDNA with an amino-terminal signal sequence. Oncogene, 4, 805-806.
21. Tahira, T. Ishizaka, Y., Itoh, F., Sugimura, T. and Nagao, M. (1990) Characterization of ret proto-oncogene mRNAs encoding two isoforms of the protein product in a human neuroblastoma cell line. Oncogene, 5, 97-102.
22. Asai, N., Iwashita, T., Matsuyama, M. and Takahashi, M. (1995) Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia type 2A mutations. Mol. Cell. Biol., 15, 1613-1619.
23. Takahashi, M., Asai, N., Iwashita, T., Isomura, T., Miyazaki, K. and Matsuyama, M. (1993) Characterization of the ret proto-oncogene products expressed in mouse L cells. Oncogene, 8, 2925-2929.
24. Mulligan, L.M., Kwok, J.B.J., Healey, C.S., Elsdon, M.J., Eng, C., Gardner, E., Love, D.R., Mole, S.E., Moore, J.K., Papi, L., Ponder, M.A., Telenius, H., Tunnacliffe, A. and Ponder, B.A.J. (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature, 363, 458-460.
25. Donis-Keller, H., Dou, S., Chi, D., Carlson, K.M., Toshima, K., Lairmore, T.C., Howe, J.R., Moley, J.F., Goodfellow, P. and Wells Jr., S.A. (1993) Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum. Mol. Genet., 2, 851-856.
26. Mulligan, L.M., Eng, C., Healey, C.S., Clayton, D., Kwok, J.B.J., Gardner, E., Ponder, M.A., Frilling, A., Jackson, C.E., Lehnert, H., Neumann, H.P.H., Thibodeau, S.N. and Ponder, B.A.J. (1994) Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nature Genet., 6, 70-74.
27. Iwashita, T., Asai, N., Murakami, H., Matsuyama, M. and Takahashi, M. (1996) Identification of tyrosine residues that are essential for transforming activity of the ret proto-oncogene with MEN2A or MEN2B mutation. Oncogene, 12, 481-487.
28. Takahashi, M. (1995) Oncogenic activation of the ret proto-oncogene in thyroid cancer. Crit. Rev. Oncogenesis, 6, 35-46.
29. Santoro, M., Carlomagno, F., Romano, A., Bottaro, D.P., Dathan, N.A., Grieco, M., Fusco, A., Vecchio, G., Matoskova, B., Kraus, M.H. and Di Fiore, P.P. (1995) Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science, 267, 381-383.
30. Pachnis, V., Mankoo, B. and Costantini, F. (1993) Expression of the c-ret proto-oncogene during mouse embryogenesis. Development, 119, 1005-1017.
31. Tsuzuki, T., Takahashi, M., Asai, N., Iwashita, T., Matsuyama, M. and Asai, J. (1995) Spatial and temporal expression of the ret proto-oncogene product in embryonic, infant and adult rat tissues. Oncogene. 10, 191-198.
32. Moore, M.W., Klein, R.D., Farinas, I., Sauer, H., Armanini, M., Phillips, H., Reichardt, L.F., Ryan, A.M., Carver-Moore, K. and Rosenthal, A. (1996) Renal and neuronal abnormalities in mice lacking GDNF. Nature, 382, 76-79.
33. Treanor, J., Goodman, L., de Sauvage, F., Stone, D., Poulsen, K., Beck, K., Gray, C., Armanini, M., Pollock, R.A., Hefti, F., Phillips, H., Goddard, A., Davies, A., Asai, N., Takahashi, M., Vandlen, R., Henderson, C. and Rosenthal, A. (1996) Characterization of a multicomponent receptor for GDNF. Nature, 382, 80-83.
34. Jing, S., Wen, D., Yu, Y., Holst, P. L., Luo, Y., Fang, M., Tamir, R., Antonio, L., Hu, Z., Cupples, R., Louis, J. C., Hu, S., Altrock, B. W. and Fox, G. M. (1996) GDNF-induced activation of the Ret protein tyrosine kinase is mediated by GDNFR-α, a novel receptor for GDNF. Cell, 85, 1113-1124.
35. Flanagan, J. G. and Leder, P. (1990) The kit ligand: A cell surface molecule altered in steel mutant fibroblasts. Cell, 63, 185-194.
36. Takahashi, M., Buma, Y. and Taniguchi, M. (1991) Identification of the ret proto-oncogene products in neuroblastoma and leukemia cells. Oncogene, 6, 297-301.